Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol. 2010;101:476–80. https://doi.org/10.1002/jso.21522.

Article  PubMed  Google Scholar 

Facciorusso A, Di Maso M, Muscatiello N. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: a meta-analysis. Dig Liver Dis. 2016;48:571–7. https://doi.org/10.1016/j.dld.2016.02.005.

Article  CAS  PubMed  Google Scholar 

Labeur TA, Runge JH, Klompenhouwer EG, Klümpen HJ, Takkenberg RB, van Delden OM.  Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation. Abdom Radiol. 2019;44:2740–50. https://doi.org/10.1007/s00261-019-02030-2.

Article  Google Scholar 

Tohra S, Duseja A, Taneja S, et al. Experience with changing etiology and nontransplant curative treatment modalities for hepatocellular carcinoma in a real-life setting—a retrospective descriptive analysis. J Clin Exp Hepatol. 2021;11:682–90. https://doi.org/10.1016/j.jceh.2021.02.002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shetty VV, Kellarai A. Comprehensive review of hepatocellular carcinoma in India: current challenges and future directions. JCO Glob Oncol. 2022;8:e2200118. https://doi.org/10.1200/GO.22.00118.

Article  PubMed  PubMed Central  Google Scholar 

Carbonell G, Taouli B. Abbreviated MR protocols for chronic liver disease and liver cancer. Magn Reson Imaging Clin N Am. 2021;29:321–7. https://doi.org/10.1016/j.mric.2021.05.003.

Article  PubMed  PubMed Central  Google Scholar 

Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78:1922–65. https://doi.org/10.1097/HEP.0000000000000466.

Article  PubMed  Google Scholar 

Ronot M, Nahon P, Rimola J. Screening of liver cancer with abbreviated MRI. Hepatology. 2023;78:670–86. https://doi.org/10.1097/HEP.0000000000000339.

Article  PubMed  Google Scholar 

An J, Peña MA, Cunha GM, et al. Abbreviated MRI for hepatocel-lular carcinoma screening and surveillance. Radiographics. 2020;40:1916–31. https://doi.org/10.1148/rg.2020200104.

Article  PubMed  Google Scholar 

Vietti Violi N, Fowler KJ, Sirlin CB, Taouli B. Abbreviated magnetic resonance imaging for HCC surveillance. Clin Liver Dis (Hoboken). 2021;17:133–8. https://doi.org/10.1002/cld.1016.

Article  PubMed  PubMed Central  Google Scholar 

Park HJ, Seo N, Kim SY. Current landscape and future perspectives of abbreviated MRI for hepatocellular carcinoma surveillance. Korean J Radiol. 2022;23:598–614. https://doi.org/10.3348/kjr.2021.0896.

Article  PubMed  PubMed Central  Google Scholar 

Soundararajan R, Pooja AB, Gupta P, et al. Diagnostic performance of abbreviated MRI for HCC detection in patients with non-alcoholic fatty liver disease. J Clin Exp Hepatol. 2024;14:101276. https://doi.org/10.1016/j.jceh.2023.08.012.

Article  CAS  PubMed  Google Scholar 

Pavlides M, Francis S, Barnes E. Abbreviated MRI to screen for HCC in patients with cirrhosis. A step forward but a long road ahead. J Hepatol. 2022;76:981–2. https://doi.org/10.1016/j.jhep.2021.10.027.

Article  PubMed  Google Scholar 

Gupta P, Soundararajan R, Patel A, Kumar-M P, Sharma V, Kalra N. Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol. 2021;75:108–19. https://doi.org/10.1016/j.jhep.2021.01.041.

Article  PubMed  Google Scholar 

Marks RM, Ryan A, Heba ER, et al. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol. 2015;204:527–35. https://doi.org/10.2214/AJR.14.12986.

Article  PubMed  Google Scholar 

Winder M, Grabowska S, Hitnarowicz A, Barczyk-Gutkowska A, Gruszczyńska K, Steinhof-Radwańska K. The application of abbreviated MRI protocols in malignant liver lesions surveillance. Eur J Radiol. 2023;164:110840. https://doi.org/10.1016/j.ejrad.2023.110840.

Article  PubMed  Google Scholar 

Chernyak V, Fowler KJ, Kamaya A, et al. Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289:816–30. https://doi.org/10.1148/radiol.2018181494.

Article  PubMed  Google Scholar 

Besa C, Lewis S, Pandharipande PV, et al. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid. Abdom Radiol. 2017;42:179–90. https://doi.org/10.1007/s00261-016-0841-5.

Article  Google Scholar 

Chan MV, Huo YR, Trieu N, et al. Noncontrast MRI for hepatocellular carcinoma detection: a systematic review and metaanalysis - a potential surveillance tool? Clin Gastroenterol Hepatol. 2022;20:44–56.e2. https://doi.org/10.1016/j.cgh.2021.02.036.

Article  PubMed  Google Scholar 

Singal A, Volk ML, Waljee A, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47. https://doi.org/10.1111/j.1365-2036.2009.04014.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Girardet R, Dubois M, Manasseh G, et al. The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening. Eur Radiol. 2023;33:6929–38. https://doi.org/10.1007/s00330-023-09906-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JY, Huo EJ, Weinstein S, et al. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma. Abdom Radiol. 2018;43:1627–33. https://doi.org/10.1007/s00261-017-1339-5.

Article  Google Scholar 

Yokoo T, Masaki N, Parikh ND, et al. Multicenter validation of abbreviated MRI for detecting early-stage hepatocellular carcinoma. Radiology. 2023;307:e220917. https://doi.org/10.1148/radiol.220917.

Article  PubMed  Google Scholar 

Park HJ, Kim SY, Singal AG, et al. Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients. Liver Int. 2022;42:2080–92. https://doi.org/10.1111/liv.15110.

Article  CAS  PubMed  Google Scholar 

Kimoto E, Yoshida K, Balogh LM, et al. Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes. Mol Pharm. 2012;9:3535–42. https://doi.org/10.1021/mp300379q.

Article  CAS  PubMed  Google Scholar 

Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. EurRadiol. 2011;21:2056–66. https://doi.org/10.1007/s00330-011-2165-8.

Article  Google Scholar 

Lee JH, Kim YK, Min JH, et al. Comparison of noncontrast, dynamic, and hepatobiliary phase abbreviated MRI protocols for detection of hepatic malignancies. Clin Imaging. 2023;101:206–14. https://doi.org/10.1016/j.clinimag.2023.05.018.

Article  PubMed  Google Scholar 

Kim YK, Kim YK, Park HJ, et al. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma. Magn Reson Imaging. 2014;32:610–8. https://doi.org/10.1016/j.mri.2013.12.021.

Article  PubMed  Google Scholar 

Jalli R, Jafari SH, Sefidbakht S, Kazemi K. Comparison of the accuracy of DWI and ultrasonography in screening hepatocellular carcinoma in patients with chronic liver disease. Iran J Radiol. 2015;12:e12708. https://doi.org/10.5812/iranjradiol.12708.

Article  PubMed  PubMed Central  Google Scholar 

Sutherland T, Watts J, Ryan M, et al. Diffusion-weighted MRI for hepatocellular carcinoma screening in chronic liver disease: direct comparison with ultrasound screening. J Med Imaging Radiat Oncol. 2017;61:34–9. https://doi.org/10.1111/1754-9485.12513.

Article  PubMed  Google Scholar 

Han S, Choi JI, Park MY, et al. The diagnostic performance of liver MRI without intravenous contrast for detecting hepatocellular carcinoma: a case-controlled feasibility study. Korean J Radiol. 2018;19:568–77. https://doi.org/10.3348/kjr.2018.19.4.568.

Article  PubMed  PubMed Central  Google Scholar 

Whang S, Choi MH, Choi JI, et al. Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas. Eur Radiol. 2020;30:4150–63. https://doi.org/10.1007/s00330-020-06754-4.

Article  CAS  PubMed  Google Scholar 

Kim JS, Lee JK, Baek SY, Yun HI. Diagnostic performance of a minimized protocol of non-contrast MRI for hepatocellular carcinoma surveillance. Abdom Radiol (NY). 2020;45:211–9. https://doi.org/10.1007/s00261-019-02277-9.

Article  PubMed  Google Scholar 

Park HJ, Jang HY, Kim SY, et al. Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: comparison with ultrasound. J Hepatol. 2020;72:718–24. https://doi.org/10.1016/j.jhep.2019.12.001.

Article  PubMed  Google Scholar 

Ahmed NNA, El Gaafary SM, Elia RZ, Abdulhafiz EM. Role of abbreviated MRI protocol for screening of HCC in HCV related cirrhotic patients prior to direct-acting antiviral treatment. Egypt J Radiol Nucl Med. 2020;51:102. https://doi.org/10.1186/s43055-020-00199-x.